Company type | Venture Capital |
---|---|
Industry | Venture Capital |
Predecessor | IP Group |
Headquarters | Oxford , UK |
Key people |
|
Website |
oxfordscienceenterprises |
Oxford Sciences Enterprises is an early-stage venture capital firm with over $800M in AUM based in Oxford, UK. [1] It operates in partnership with the University of Oxford, as the university's preferred investor, several prominent financiers back the firm, including Google Ventures, Sequoia Capital, Tencent, Huawei and Invesco. [2] [3] The firm uses academic research from the university's science departments to form commercial businesses, also known as spin-outs. [4] [5] [6]
The company was founded in 2015 by David Norwood, who was previously the founder of the IP Group, which initially invested only in spinoffs from the university's chemistry department. [7] Oxford Sciences Enterprises initially raised £600m from investors, which included Lansdowne Partners and Google Ventures. [8] [9] [10] [11] Google Ventures partners Tom Hulme and Dr Krishna Yeshwant also joined OSI's advisory board, along with Google AI researcher Demis Hassabis, founder of DeepMind. [8] [12]
Charles Conn, previously CEO of the Rhodes Trust and former McKinsey partner, was appointed CEO in March 2019. Former Google CFO Patrick Pichette joined him as Chair of the board. [7] However, Conn departed in November 2019 and Pichette shortly after. OSI's CFO became acting CEO until the appointment of Alexis Dormandy, another former McKinsey partner, in October 2020 [13]
In September 2023 Ed Bussey was named CEO of the company, and at the same time Jack Edmondson was appointed to the newly created role of CIO. [14] [15] [16] [17]
OSE is structured differently from other venture capital firms, being an evergreen patient capital, privately held company and not bound by a limited partnership agreement. [18] [19] [20] As such, the company holds long-term investments, pursuing a patient capital model. OSI differentiates itself from classic venture firms because of its relationship with the university. [21] Unlike most university-linked venture firms, Oxford University is a shareholder in the company, with OSI receiving half of the university's stake in the intellectual property of a spinout. [22]
OSE works with the university's technology transfer office, Oxford University Innovation, which helps manage the intellectual property and patent estate of the university. [23]
In July 2019, The company announced an investment from Chinese telecommunications company Huawei owns £4.1m in OSI shares (approximately 0.7% of the total fund). [24]
{{
cite web}}
: |first=
has generic name (
help)CS1 maint: multiple names: authors list (
link)
{{
cite web}}
: CS1 maint: numeric names: authors list (
link)
Company type | Venture Capital |
---|---|
Industry | Venture Capital |
Predecessor | IP Group |
Headquarters | Oxford , UK |
Key people |
|
Website |
oxfordscienceenterprises |
Oxford Sciences Enterprises is an early-stage venture capital firm with over $800M in AUM based in Oxford, UK. [1] It operates in partnership with the University of Oxford, as the university's preferred investor, several prominent financiers back the firm, including Google Ventures, Sequoia Capital, Tencent, Huawei and Invesco. [2] [3] The firm uses academic research from the university's science departments to form commercial businesses, also known as spin-outs. [4] [5] [6]
The company was founded in 2015 by David Norwood, who was previously the founder of the IP Group, which initially invested only in spinoffs from the university's chemistry department. [7] Oxford Sciences Enterprises initially raised £600m from investors, which included Lansdowne Partners and Google Ventures. [8] [9] [10] [11] Google Ventures partners Tom Hulme and Dr Krishna Yeshwant also joined OSI's advisory board, along with Google AI researcher Demis Hassabis, founder of DeepMind. [8] [12]
Charles Conn, previously CEO of the Rhodes Trust and former McKinsey partner, was appointed CEO in March 2019. Former Google CFO Patrick Pichette joined him as Chair of the board. [7] However, Conn departed in November 2019 and Pichette shortly after. OSI's CFO became acting CEO until the appointment of Alexis Dormandy, another former McKinsey partner, in October 2020 [13]
In September 2023 Ed Bussey was named CEO of the company, and at the same time Jack Edmondson was appointed to the newly created role of CIO. [14] [15] [16] [17]
OSE is structured differently from other venture capital firms, being an evergreen patient capital, privately held company and not bound by a limited partnership agreement. [18] [19] [20] As such, the company holds long-term investments, pursuing a patient capital model. OSI differentiates itself from classic venture firms because of its relationship with the university. [21] Unlike most university-linked venture firms, Oxford University is a shareholder in the company, with OSI receiving half of the university's stake in the intellectual property of a spinout. [22]
OSE works with the university's technology transfer office, Oxford University Innovation, which helps manage the intellectual property and patent estate of the university. [23]
In July 2019, The company announced an investment from Chinese telecommunications company Huawei owns £4.1m in OSI shares (approximately 0.7% of the total fund). [24]
{{
cite web}}
: |first=
has generic name (
help)CS1 maint: multiple names: authors list (
link)
{{
cite web}}
: CS1 maint: numeric names: authors list (
link)